loading...| Preferred Name |
dromostanolone |
|
| Synonyms |
17 beta-hydroxy-2 alpha-methyl-5 alpha-androstan-3-one |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C100263 |
|
| altLabel |
17 beta-hydroxy-2 alpha-methyl-5 alpha-androstan-3-one drostanolon drostanolone dromostanolone, (5alpha,17beta)-isomer methalone prometholone |
|
| cui |
C0127797 C0138611 C0960041 C0058753 |
|
| HM |
D000732 |
|
| Inverse of RB |
3232-69-7 7DR7H00HDT |
|
| Mapped to | ||
| MDA |
19860730 |
|
| MeSH Frequency |
22 |
|
| MMR |
20121105 |
|
| notation |
C100263 |
|
| PI |
major descriptor (66-86); file maintained to ANDROSTANOLS |
|
| prefLabel |
dromostanolone |
|
| RR |
58-19-5 (dromostanolone) 3232-69-7 ((5alpha,17beta)-isomer) |
|
| SC |
1 |
|
| Scope Statement |
synthetic anabolic androgenic steroid used to lower plasma cholesterol & as antineoplastic agent in advanced breast neoplasms; major descriptor (66-86); on-line search ANDROSTANOLS (80-86); ANDROSTANES (68-86); INDEX MEDICUS search DROMOSTANOLONE (66-86); RN given refers to (2alpha,5alpha,17beta)-isomer |
|
| SRC |
Vopr Onkol 1983;29(3):82 |
|
| TERMUI |
T293248 T293251 T357507 T293246 T293247 T293250 T293249 |
|
| TH |
FDA SRS (2013) INN (19XX) NLM (1986) |
|
| tui |
T109 T121 |